Nov 16, 2005|
FMCG: The smaller the better?
Last week, we wrote about how large FMCG companies performed in the September quarter 2005 in comparison to the same quarter the previous year and the picture was quite decent. Today, we compare 5 other FMCG companies, albeit this time from the mid-cap space. The five companies included here are Dabur, Godrej Consumer Products, Colgate, Marico and Pidilite.
|Operating Profit (EBDIT)
|Operating Profit Margin (%)
|Profit before Tax
|Profit after Tax
|Net profit margin (%)
|Effective tax rate (%)
Something about the sector...
Today, the FMCG sector is the fourth-largest sector in the Indian economy, with an estimated total market size of around Rs 450 bn. Further, the growth potential for all the FMCG companies is huge, as the per capita consumption of almost all products in the country is amongst the lowest in the world. Further, if these companies can change consumer's mindset and offer new generation products, they would be able to generate higher growth. It is quality and innovation of products, which is really driving demand.
What does the report card say this time around?
The consolidated topline grew by around 16% YoY in the September quarter (around 15% YoY growth in the case of large-caps) indicating that smaller FMCG companies have benefited more from the increase in consumer spending. Also, the rise in expenditure was at a slower pace than the sales growth, which could be attributed to lower other expenditure and control over marketing expenses as a percentage of sales, which the smaller companies have been working on for sometime now. This resulted in operating margins expand by 110 basis points (down 60 basis points for large FMCG companies). Depreciation increased by 3% YoY, mainly because of Dabur's acquisition of Balsara, which resulted in an 8% YoY rise for the company. Interest costs have increased by around 36% as companies like Dabur have taken some debt to fund its recent acquisition. Also, other income during the period has almost doubled, indicating higher investment income.
All these factors put together, resulted in a 41% YoY PAT growth for mid-cap FMCG companies, compared to an 11% rise in profits for the larger ones. Of the 5 companies, Dabur and Godrej Consumers reported 49% and 57% YoY bottomline growth respectively. None of the companies posted a net profit growth of less than 10%
What to expect?
We believe that selective mid-cap FMCG companies are a good investment option, though their commanding valuations, as compared to the well-established larger companies, make them somewhat risky. Nonetheless, in our view, the smaller FMCG companies have the potential to explore the untapped markets and are already gaining acceptance.
Also, since these companies follow a different strategy by offering higher margins to wholesalers and retailers, it results in their products being pushed more than others. Further, smaller companies have started exploring rural markets, not through their own network as it is an expensive affair, but through other larger companies networks. For example, Godrej Consumer has tied up with ITC to sell its soaps through the latter's E-Choupal network. However, the only drawback in this strategy is that of marginally lower margins.
The FMCG sector, after having underperformed for some time, is on the path to recovery, with acceleration in rural growth, increasing consumer spending along with the shift in product preference towards those being offered by the newer entrants. With greater possibility of oil prices softening in the medium-term, pressure on operating margins of FMCG companies would stand reduced. That said, it is pertinent to not only look at growth rates, but also the sustainability of the same over the long-term. As organised retailing gains momentum, smaller players are likely to be squeezed more than the bigger FMCG majors by virtue of their size and the number of product offering. To conclude, current margins are no indicator of what lies ahead!
More Views on News
Aug 9, 2017
While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Dec 9, 2016
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
Nov 30, 2016
Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
Nov 30, 2016
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
Nov 28, 2016
Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 4, 2017
The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407